<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Synerlab Archives - Slice of Healthcare</title>
	<atom:link href="https://sliceofhealthcare.com/tag/synerlab/feed/" rel="self" type="application/rss+xml" />
	<link>https://sliceofhealthcare.com/tag/synerlab/</link>
	<description>Redefining Healthcare Media.</description>
	<lastBuildDate>Mon, 30 Sep 2024 05:38:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.2</generator>

<image>
	<url>https://i0.wp.com/sliceofhealthcare.com/wp-content/uploads/2023/05/cropped-Site-icon-slice-of-healthcare-2.png?fit=32%2C32&#038;ssl=1</url>
	<title>Synerlab Archives - Slice of Healthcare</title>
	<link>https://sliceofhealthcare.com/tag/synerlab/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">190433015</site>	<item>
		<title>Blue Wolf Capital Acquires European Pharma Facilities from Recipharm</title>
		<link>https://sliceofhealthcare.com/blue-wolf-capital-acquires-european-pharma-facilities-from-recipharm/</link>
		
		<dc:creator><![CDATA[Chris-Anne Roque]]></dc:creator>
		<pubDate>Mon, 30 Sep 2024 05:37:52 +0000</pubDate>
				<category><![CDATA[Growth News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Amy Mort]]></category>
		<category><![CDATA[Avet Pharmaceuticals]]></category>
		<category><![CDATA[Blue Wolf Capital Partners LLC]]></category>
		<category><![CDATA[Bruce Vielle]]></category>
		<category><![CDATA[George Svokos]]></category>
		<category><![CDATA[Peter Kruger]]></category>
		<category><![CDATA[Recipharm]]></category>
		<category><![CDATA[Resilience]]></category>
		<category><![CDATA[Rich Fenton]]></category>
		<category><![CDATA[Saurabh Singh]]></category>
		<category><![CDATA[Shashank PateL]]></category>
		<category><![CDATA[Steve Leonard]]></category>
		<category><![CDATA[Synerlab]]></category>
		<category><![CDATA[William Marth]]></category>
		<guid isPermaLink="false">https://sliceofhealthcare.com/?p=36945</guid>

					<description><![CDATA[<p>Key Highlights Blue Wolf Capital acquires seven European facilities from Recipharm, specializing in oral solid, semi-solid, and liquid dosage pharmaceutical products.&#8230;</p>
<p>The post <a href="https://sliceofhealthcare.com/blue-wolf-capital-acquires-european-pharma-facilities-from-recipharm/">Blue Wolf Capital Acquires European Pharma Facilities from Recipharm</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="36945" class="elementor elementor-36945" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-53265ad elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="53265ad" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b1fd0d8" data-id="b1fd0d8" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-219a45b elementor-widget elementor-widget-heading" data-id="219a45b" data-element_type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h2 id="key-highlights" class="elementor-heading-title elementor-size-default">Key Highlights</h2>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-ea205cb elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="ea205cb" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-37761df" data-id="37761df" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-6d09b4b elementor-widget elementor-widget-text-editor" data-id="6d09b4b" data-element_type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<ul><li><strong>Blue Wolf Capital</strong> acquires <strong>seven European facilities</strong> from Recipharm, specializing in oral solid, semi-solid, and liquid dosage pharmaceutical products.</li><li>The acquisition supports Blue Wolf’s goal to build an <strong>industry-leading CDMO platform</strong>.</li><li>Blue Wolf also plans to acquire <strong>Synerlab</strong>, a CDMO in France and Spain, pending regulatory approval.</li><li><strong>Bruce Vielle</strong> will serve as <strong>CEO of the combined organization</strong>, supported by a team of industry experts.</li></ul><p><b>Source: </b><a href="https://www.businesswire.com/news/home/20240925679693/en/Blue-Wolf-Capital-to-Create-New-CDMO-Platform">Business Wire</a></p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-e90ba87 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="e90ba87" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0c976b7" data-id="0c976b7" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-5516a40 elementor-widget elementor-widget-heading" data-id="5516a40" data-element_type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h2 id="notable-quotes" class="elementor-heading-title elementor-size-default">Notable Quotes</h2>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-d697cb9 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="d697cb9" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0a4aada" data-id="0a4aada" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-91b3c7e elementor-widget elementor-widget-text-editor" data-id="91b3c7e" data-element_type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<ul><li>&#8220;By honoring both cultures, we will create an even stronger and more exciting one to serve our customers and patients.” <strong>— </strong><strong>Bruce Vielle, Chief Executive Officer at Synerlab</strong></li><li>“We see significant growth potential in these facilities and look forward to building a best-in-class CDMO focused on delivering outstanding service and high-quality pharmaceutical products.” <strong>— Shashank Patel, Principal at Blue Wolf</strong></li></ul>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-de5db98 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="de5db98" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-49139f5" data-id="49139f5" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-416ad5a elementor-widget elementor-widget-heading" data-id="416ad5a" data-element_type="widget" data-widget_type="heading.default">
				<div class="elementor-widget-container">
					<h2 id="sohcs-take" class="elementor-heading-title elementor-size-default">SoHC's Take</h2>				</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-815da73 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="815da73" data-element_type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123f65b" data-id="123f65b" data-element_type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-e1455ae elementor-widget elementor-widget-text-editor" data-id="e1455ae" data-element_type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<p>This acquisition marks a significant milestone for Blue Wolf Capital, as it not only strengthens its presence in the pharmaceutical manufacturing space but also underscores its commitment to building a leading CDMO platform in Europe. With a highly experienced leadership team at the helm and the strategic acquisition of Synerlab, Blue Wolf is well-positioned to capitalize on market demand and regulatory compliance for high-quality pharmaceutical products. The anticipated growth of this combined platform will likely enhance its market reach across Europe and beyond, contributing to its long-term success.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
		<div class="elementor-element elementor-element-ea8e122 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no e-con e-parent" data-id="ea8e122" data-element_type="container">
					<div class="e-con-inner">
					</div>
				</div>
				</div>
		<p><a class="a2a_button_linkedin" href="https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&amp;linkname=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" title="LinkedIn" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&amp;linkname=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&amp;linkname=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&amp;linkname=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" title="Email" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_copy_link" href="https://www.addtoany.com/add_to/copy_link?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&amp;linkname=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" title="Copy Link" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fsliceofhealthcare.com%2Fblue-wolf-capital-acquires-european-pharma-facilities-from-recipharm%2F&#038;title=Blue%20Wolf%20Capital%20Acquires%20European%20Pharma%20Facilities%20from%20Recipharm" data-a2a-url="https://sliceofhealthcare.com/blue-wolf-capital-acquires-european-pharma-facilities-from-recipharm/" data-a2a-title="Blue Wolf Capital Acquires European Pharma Facilities from Recipharm"></a></p><p>The post <a href="https://sliceofhealthcare.com/blue-wolf-capital-acquires-european-pharma-facilities-from-recipharm/">Blue Wolf Capital Acquires European Pharma Facilities from Recipharm</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">36945</post-id>	</item>
	</channel>
</rss>